Home › Synta Pharmaceuticals Closes Public Offering of Common Stock
 

Keywords :   


Synta Pharmaceuticals Closes Public Offering of Common Stock

2013-11-19 12:52:57| Biotech - Topix.net

Gross proceeds to Synta are approximately $60.4 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Synta.

Tags: public stock common offering

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.09Tropical Depression Twelve Public Advisory Number 1
29.09Summary for Tropical Depression Twelve (AT2/AL122024)
29.09Tropical Depression Twelve Wind Speed Probabilities Number 1
29.09Tropical Storm Joyce Forecast Discussion Number 10
29.09Tropical Depression Twelve Forecast Discussion Number 1
29.09Tropical Depression Twelve Graphics
29.09Tropical Storm Joyce Graphics
29.09Tropical Storm Joyce Wind Speed Probabilities Number 10
More »